Help. Zanubrutinib vs Bendamustine and rituximab vs DRC for B cell type Waldenström and indolent lymphoma
Hi everyone,
My mum 70F has been diagnosed with B cell type indolent LPL/marginal lymphoma because her MYD88 has come as negative.
They have said she has waldenstroms (WM).
We’ve seen two doctors both giving different treatment options.
One is saying to go for zanubrutinib as she’s on the older side and there will be side effects to chemo.
The other is saying to go for chemo and if she needs to take Zanubrutinib later if she relapses then she can take it then instead of wearing it off now.
We are extremely conflicted as all of this is like diving into the unknown for us and we have no insight into either of these treatments.
Can anyone advise based on what they know or have been through.